Exane BNP Paribas Downgrades Morgan Stanley to Neutral, Announces $85 Price Target
Portfolio Pulse from Benzinga Newsdesk
Exane BNP Paribas analyst Jeremy Sigee downgraded Morgan Stanley (NYSE:MS) from Outperform to Neutral and set a price target of $85.
November 20, 2023 | 10:49 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Morgan Stanley was downgraded by Exane BNP Paribas from Outperform to Neutral with a price target of $85.
Downgrades by analysts can lead to a negative perception among investors and potentially cause a short-term decline in the stock's price. The new price target of $85 provides a reference point that may influence investor expectations and trading behavior.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100